Ocera Therapeutics Announces Staffing Transition
11 déc. 2013 16h00 HE
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif., Dec. 11, 2013 (GLOBE NEWSWIRE) -- Ocera Therapeutics (Nasdaq:OCRX) today announced that David S. Moore, its chief business officer, will be leaving Ocera to pursue other...
Ocera Therapeutics to Present at Piper Jaffrey Healthcare Conference
26 nov. 2013 16h00 HE
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif., Nov. 26, 2013 (GLOBE NEWSWIRE) -- Ocera Therapeutics (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced...
Ocera Reports Third Quarter Business Update and Financial Results
13 nov. 2013 17h00 HE
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif., Nov. 13, 2013 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a biopharmaceutical company focused on innovative therapeutics for orphan liver disease, announced today...
Ocera Therapeutics Announces $28 Million Private Placement
06 nov. 2013 08h30 HE
|
Ocera Therapeutics, Inc.
SAN DIEGO, Nov. 6, 2013 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a biopharmaceutical company focused on innovative therapeutics for orphan liver disease, announced today that it has...
Ocera Therapeutics to Present at BIO Investor on October 8, 2013
25 sept. 2013 05h10 HE
|
Ocera Therapeutics, Inc.
SAN DIEGO, Sept. 25, 2013 (GLOBE NEWSWIRE) -- Ocera Therapeutics (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced that...
Ocera Announces Post-Merger Closure of Quebec Research Site
17 sept. 2013 16h20 HE
|
Ocera Therapeutics, Inc.
SAN DIEGO, Sept. 17, 2013 (GLOBE NEWSWIRE) -- Ocera Therapeutics (Nasdaq:OCRX), a clinical stage biopharmaceutical company focusing on acute and chronic orphan liver diseases, today announced a...
Jeryl L. Hilleman Joins Ocera Therapeutics as Chief Financial Officer
03 sept. 2013 05h10 HE
|
Ocera Therapeutics, Inc.
SAN DIEGO, Sept. 3, 2013 (GLOBE NEWSWIRE) -- Ocera Therapeutics (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced that Jeryl...
Ocera Therapeutics Announces Second Quarter 2013 Financial Results
13 août 2013 17h52 HE
|
Ocera Therapeutics, Inc.
SAN DIEGO, Aug. 13, 2013 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. ("Ocera" or the "Company") (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on the development and...
Ocera Therapeutics to Report Second Quarter 2013 Financial Results
26 juil. 2013 05h10 HE
|
Ocera Therapeutics, Inc.
SAN DIEGO, July 26, 2013 (GLOBE NEWSWIRE) -- Ocera Therapeutics (Nasdaq:OCRX) today announced that the Company will report second quarter 2013 financial results after the close of the market on...
Ocera Therapeutics Announces Completion of Merger With Tranzyme
15 juil. 2013 12h04 HE
|
Ocera Therapeutics, Inc.
SAN DIEGO, July 15, 2013 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. ("Ocera"), a clinical stage biopharmaceutical company developing novel therapeutics for orphan liver diseases, and Tranzyme, Inc....